Andra AP fonden Decreases Holdings in Healthpeak Properties, Inc. (NYSE:DOC)

Andra AP fonden trimmed its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 9.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 343,300 shares of the real estate investment trust’s stock after selling 37,900 shares during the period. Andra AP fonden’s holdings in Healthpeak Properties were worth $6,959,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Avior Wealth Management LLC bought a new stake in Healthpeak Properties in the third quarter worth about $37,000. Groupama Asset Managment bought a new stake in shares of Healthpeak Properties in the 3rd quarter worth approximately $37,000. Capital Performance Advisors LLP purchased a new position in Healthpeak Properties in the third quarter valued at approximately $42,000. Wiser Advisor Group LLC bought a new position in Healthpeak Properties during the third quarter valued at $42,000. Finally, Continuum Advisory LLC purchased a new stake in Healthpeak Properties in the third quarter worth $44,000. 93.57% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Mizuho dropped their price target on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research report on Thursday, December 5th. Scotiabank cut their target price on shares of Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating for the company in a research report on Friday, February 28th. Robert W. Baird lowered their price target on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research report on Tuesday, February 11th. Morgan Stanley raised shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price objective for the company in a report on Wednesday, January 15th. Finally, Wedbush reduced their price objective on shares of Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating for the company in a research note on Friday, February 14th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $23.92.

Healthpeak Properties Price Performance

Shares of Healthpeak Properties stock opened at $20.52 on Friday. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35. Healthpeak Properties, Inc. has a 52-week low of $16.66 and a 52-week high of $23.26. The company has a fifty day moving average of $20.20 and a 200-day moving average of $21.30. The stock has a market capitalization of $14.35 billion, a price-to-earnings ratio of 58.62, a price-to-earnings-growth ratio of 2.17 and a beta of 1.14.

Healthpeak Properties Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Friday, February 14th were paid a dividend of $0.305 per share. This is a boost from Healthpeak Properties’s previous quarterly dividend of $0.30. This represents a $1.22 dividend on an annualized basis and a dividend yield of 5.95%. The ex-dividend date was Friday, February 14th. Healthpeak Properties’s dividend payout ratio (DPR) is 348.57%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.